The U.S. Food and Drug Administration in collaboration with the Reagan-Udall Foundation for the FDA will hold a virtual public workshop to discuss critical questions around access to naloxone, a drug used to reverse opioid overdoses.
Read more: FDA, Reagan-Udall Foundation to Hold Important Public Workshop to Discuss Naloxone Access